Normal view MARC view ISBD view

Bro, Susanne

Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice. [electronic resource] - Arteriosclerosis, thrombosis, and vascular biology May 2007 - 1080-6 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

ISSN: 1524-4636

Standard No.: 10.1161/ATVBAHA.107.139634 doi

Subjects--Topical Terms:
Angiotensin II Type 1 Receptor Blockers--pharmacology
Angiotensin-Converting Enzyme Inhibitors--pharmacology
Animals
Antibodies, Anti-Idiotypic--blood
Aorta, Thoracic--metabolism
Aortic Diseases--blood
Apolipoproteins E--deficiency
Atherosclerosis--blood
Blood Pressure--drug effects
Disease Models, Animal
Disease Progression
Drosophila Proteins
Enalapril--pharmacology
Follow-Up Studies
Gene Expression--drug effects
Immunoglobulin G--immunology
Immunoglobulin M--immunology
Intercellular Adhesion Molecule-1--genetics
Lipoproteins, LDL--immunology
Losartan--pharmacology
Mice
Nephrectomy--adverse effects
Oxidation-Reduction
Peptidyl-Dipeptidase A--blood
Prognosis
RNA, Messenger--genetics
Receptors, Cell Surface
Renin-Angiotensin System--drug effects
Uremia--blood
Vascular Cell Adhesion Molecule-1--genetics